Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.

Purpose: To investigate the role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage.

Methods: This is a prospective randomized control trial. Twenty eyes of 20 patients with dense vitreous hemorrhage because of Eales disease were randomly distributed in Group 1 (n = 10) and Group 2 (n = 10).